Biogen, Elan Face Wrongful Death Suit
- Share via
A Colorado widower whose wife died after participating in a clinical trial for one of Biogen Idec’s multiple sclerosis drugs has sued the company, saying his wife “didn’t have to die.”
The wrongful death suit filed on behalf of Walter Smith, of Colorado Springs, also named Cambridge, Mass.,-based Biogen Idec’s partner, Elan Pharmaceuticals of Ireland.
Smith’s wife, Anita, 46, died of the rare brain disease progressive multifocal leukoencephalopathy after taking part in a clinical trial of the drug, Tysabri. She was one of two patients who died from the disease, prompting the two companies to pull Tysabri from the market this year.
A spokesman for Biogen Idec declined to comment.
Inside the business of entertainment
The Wide Shot brings you news, analysis and insights on everything from streaming wars to production — and what it all means for the future.
You may occasionally receive promotional content from the Los Angeles Times.
